Increase in tumor oxygenation and radiosensitivity caused by pentoxifylline.
The effects of pentoxifylline (PTX), a drug commonly used for vascular disorders in humans, on the pO2 in SCK tumors of A/J mice and FSa-II tumors of C3Heb/FeJ mice as well as on the radioresponse of SCK tumors were investigated. When the host mice were injected intraperitoneally (ip) with 5 mg/kg PTX, the tumor pO2 increased slowly, peaked 20-50 min postinjection, and returned to its original level in 70-90 min. The magnitude of the increase in tumor pO2 varied markedly depending on the site and tumors. The magnitude of the changes in tumor pO2 after an ip injection of 25 or 50 mg/kg PTX was similar to that caused by 5 mg/kg PTX, but the pO2 tended to remain elevated longer with the higher dose of PTX. When the A/J mice bearing SCK tumors in the legs were injected ip with 50 mg/kg PTX and the tumors were X-irradiated 20 min later, the radiation-induced growth delay of the tumors was greater than that caused by X irradiation alone. The present study demonstrated that PTX is potentially useful for increasing the pO2 and the radioresponse of human tumors.
Song
C W
CW
University of Minnesota Medical School, Department of Therapeutic Radiology-Radiation Oncology, Minneapolis 55455.
Hasegawa
T
T
Kwon
H C
HC
Lyons
J C
JC
Levitt
S H
SH
D000818:Animals; D001785:Blood Gas Monitoring, Transcutaneous; D051379:Mice; D009132:Muscles; D009374:Neoplasms, Experimental / Q000097:blood*; D010100:Oxygen / Q000097:blood*; D010431:Pentoxifylline / Q000494:pharmacology*; D011836:Radiation Tolerance / Q000187:drug effects
D010100:Oxygen; D010431:Pentoxifylline